The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
Open accessAbstract
Since antibiotics were first used, each new introduced class has been followed by a global wave of emergent resistance, largely originating in Europe and North America where they were first used. Methicillin-resistant Staphylococcus aureus spread from the United Kingdom and North America across Europe and then Asia over more than a decade. Vancomycin-resistant enterococci and Klebsiella pneumoniae carbapenemase-producing K. pneumoniae followed a similar path some 20 years later. Recently however, metallo-β-lactamases have originated in Asia. New Delhi metallo-β-lactamase-1 was found in almost every continent within a year of its emergence in India. Metallo-β-lactamase enzymes are encoded on highly transmissible plasmids that spread rapidly between bacteria, rather than relying on clonal proliferation. Global air travel may have helped facilitate rapid dissemination. As the antibiotic pipeline offers little in the short term, our most important tools against the spread of antibiotic resistant organisms are intensified infection control, surveillance, and antimicrobial stewardship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Methicillin-resistant staphylococci
Barber, M. (1961) · Journal of Clinical Pathology · doi:10.1136/jcp.14.4.385 · Cited by 729
The evolving threat of antimicrobial resistance: Options for action
Kapi, A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 714
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Stefani, S., Chung, D. R., Lindsay, J. A., Friedrich, A. W., Kearns, A. M., Westh, H., & MacKenzie, F. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.030 · Cited by 590
Rosenthal, V. D., Bijie, H., Maki, D. G., Mehta, Y., Apisarnthanarak, A., Medeiros, E. A., Leblebicioglu, H., Fisher, D., Álvarez-Moreno, C., Khader, I. A., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.020 · Cited by 511
Self-citationCurrent Epidemiology and Growing Resistance of Gram-Negative Pathogens
Livermore, D. M. (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.2.128 · Cited by 417
Song, J.-H., Hsueh, P.-R., Chung, D. R., Ko, K. S., Kang, C.-I., Peck, K. R., Yeom, J.-S., Kim, S.-W., Chang, H.-H., Kim, Y.-S., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr024 · Cited by 389
INFECTION BY PENICILLIN-RESISTANT STAPHYLOCOCCI
Barber, M., & Rozwadowska-Dowzenko, M. (1948) · The Lancet · doi:10.1016/s0140-6736(48)92166-7 · Cited by 368
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Sánchez García, M. (2010) · JAMA · doi:10.1001/jama.2010.757 · Cited by 270
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Livermore, D. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.012 · Cited by 232
Vancomycin-resistant enterococci (VRE): transmission and control
Tacconelli, E., & Cataldo, M. A. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.026 · Cited by 190
Thati, V., Shivannavar, C. T., & Gaddad, S. M. (2011) · Indian Journal of Medical Research · doi:10.4103/0971-5916.91001 · Cited by 181
Community-acquired Acinetobacter infections
Falagas, M. E., Karveli, E. A., Kelesidis, I., & Kelesidis, T. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0365-6 · Cited by 177
AmpC -lactamases: what do we need to know for the future?
Hanson, N. D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg284 · Cited by 134
Hsu, L. Y., Tan, T. Y., Tam, V. H., Kwa, A. L., Fisher, D. A., & Koh, T. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-09 · Cited by 127
Self-citationVancomycin-resistant enterococci: 15 years and counting
Chavers, L. S., Moser, S. A., Benjamin, W. H., et al. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1375 · Cited by 122
Emergence of antibiotic resistance: need for a new paradigm
Rolain, J., Cantón, R., & Cornaglia, G. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03902.x · Cited by 74
NDM-1 and the Role of Travel in Its Dissemination
Wilson, M. E., & Chen, L. H. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0252-x · Cited by 74
Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
Ikeda-Dantsuji, Y., Hanaki, H., Sakai, F., et al. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0085-1 · Cited by 49
Antibiotic Resistance in Gram-negative Bacilli: A Singapore Perspective
Tan, T. Y., Hsu, L. Y., Koh, T. H., Ng, L. S., Tee, N. W. S., Krishnan, P., Lin, R. T. P., & Jureen, R. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p819 · Cited by 47
Bouchillon, S. K., Iredell, J. R., Barkham, T., Lee, K., & Dowzicky, M. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.031 · Cited by 38
blaOXA-181–positiveKlebsiella pneumoniae, Singapore
Koh, T. H., Cao, D. Y. H., Chan, K. S., Wijaya, L., Low, S. B. G., Lam, M. S., Ooi, E. E., & Hsu, L. Y. (2012) · Emerging infectious diseases · doi:10.3201/eid1809.111727 · Cited by 25
Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore
Sng, L., Koh, T. H., Wang, G. C. Y., Hsu, L. Y., Kapi, M., & Hiramatsu, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.11.001 · Cited by 23
Carbapenemase-ProducingKlebsiella pneumoniaein Hospital, Singapore, 2011
Venkatachalam, I., Teo, J. W. P., Balm, M. N. D., Fisher, D. A., Jureen, R., & Lin, R. T. P. (2012) · Emerging infectious diseases · doi:10.3201/eid1808.110893 · Cited by 18
Self-citationVancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report.
Ang, S., Seah, C. S., & Lee, S. T. (1996) · PubMed · Cited by 14
Cited by
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Environmental factors influencing the development and spread of antibiotic resistance
Bengtsson-Palme, J., Kristiansson, E., & Larsson, D. G. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux053 · Cited by 1,167
Li, S., Dong, S., Xu, W., Tu, S., Yan, L., Zhao, C., Ding, J., & Chen, X. (2018) · Advanced Science · doi:10.1002/advs.201700527 · Cited by 1,145
Cahill, T. J., & Prendergast, B. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00067-7 · Cited by 991
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Metadata
- Authors
- Molton, J. S., Tambyah, P. A., Ang, B. S. P., Ling, M. L., & Fisher, D. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-18
- Volume
- 56
- Issue
- 9
- Pages
- 1310-1318
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2115744065
- Cited by
- 342
- References
- 36
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.